Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor

por Chen, K H, Wada, M, Pinz, K G, Liu, H, Lin, K-W, Jares, A, Firor, A E, Shuai, X, Salman, H, Golightly, M, Lan, F, Senzel, L, Leung, E L, Jiang, X, Ma, Y
Publicado 2017